Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review
about
Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatmentPre-clinical drug prioritization via prognosis-guided genetic interaction networksAn expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer.Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trialsAntiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cellsPI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer CellsCancer imaging: is it cost-effective?The lung cancer paradox: time for action.Docetaxel in non-small cell lung cancer: a review.Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients.A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In VitroCombination therapy versus single agent chemotherapy in non-small cell lung cancer.Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patientsA Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells.Impact of anticancer drugs price cut on physician's prescription choices on first-line chemotherapy regimens and health expenditure for advanced non-small cell lung cancer in ChinaPrognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010.A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.The role of dietary nutrition in stomach cancer.Is gemcitabine cost effective in cancer treatment?Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.Docetaxel increases the risk of severe infections in the treatment of non-small cell lung cancer: a meta-analysis
P2860
Q28073057-C0EBCC72-3A29-4154-B4E6-4FA1056BBCBDQ28476072-3BC09DDD-5A80-41C2-94B3-A853B52FC4CDQ33393471-37A7A2CB-0C01-4B2D-904C-AF1A2FADF75CQ33436415-FA1A32F0-8C08-4806-917E-3EAA844B3FBFQ33739831-D4D30D3C-8C57-4E98-B3CA-3013DB34FCE8Q33912340-E452326A-D47D-481A-AF00-ACC9BF55FAE3Q34533328-D82CE4F3-409D-40A5-B8DE-92C5C4D44F26Q34938656-97538BEB-EC85-4D9A-BB6F-164E9892185AQ35095221-63439B02-1A5D-4937-A68E-7C7D180B0C03Q35537773-FF0E56D7-AF38-47FC-9DEE-10CA0599DEE9Q35602780-0C557843-31AF-47B5-83D6-84340FEB4681Q35769777-9AF21C9C-5FBB-47A3-8A3D-CEA5AF079204Q36187059-EE0AF4D0-ED4D-4798-BAA8-9D1A3B528EC7Q36222050-3EF9EF55-EC64-486F-968F-9AFA80419BB2Q36629248-1BE7095A-87FB-4330-9B7D-B9A03811EF26Q36823866-BE1A5BC3-99FC-4095-968A-B02503F68C9FQ37411137-F702FE60-1F64-497D-8F11-CFADDE8206CEQ37902246-6235B390-7288-48DA-B8BC-C9CA88D307D3Q38062490-5D2B9B16-1494-493B-8188-2D253B67D6E4Q38074876-4C510C99-FE79-4D72-B824-C7B073A30ABAQ38193079-C038B836-6F66-4505-BE9A-5B5A02B214C3Q43042833-A2B6A9BD-5A49-4466-B172-E19EA0FBB8B7Q43120677-4BC55067-03D8-43FC-8F78-B8B5E1BC89FDQ52565567-DC6BD346-8964-4708-90AD-50E6E036381DQ58718145-E7698598-B00A-44A9-868B-7B088918C2AC
P2860
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical and cost effectivenes ...... ng cancer: a systematic review
@ast
Clinical and cost effectivenes ...... ng cancer: a systematic review
@en
Clinical and cost effectivenes ...... ng cancer: a systematic review
@nl
type
label
Clinical and cost effectivenes ...... ng cancer: a systematic review
@ast
Clinical and cost effectivenes ...... ng cancer: a systematic review
@en
Clinical and cost effectivenes ...... ng cancer: a systematic review
@nl
prefLabel
Clinical and cost effectivenes ...... ng cancer: a systematic review
@ast
Clinical and cost effectivenes ...... ng cancer: a systematic review
@en
Clinical and cost effectivenes ...... ng cancer: a systematic review
@nl
P2093
P2860
P3181
P356
P1433
P1476
Clinical and cost effectivenes ...... ng cancer: a systematic review
@en
P2093
P2860
P3181
P356
10.1136/THORAX.57.1.20
P407
P577
2002-01-01T00:00:00Z